Your browser doesn't support javascript.
loading
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Zhao, Chao; Ma, Dan; Zawadzka, Malgorzata; Fancy, Stephen P J; Elis-Williams, Lowri; Bouvier, Guy; Stockley, John H; de Castro, Glaucia Monteiro; Wang, Bowei; Jacobs, Sabrina; Casaccia, Patrizia; Franklin, Robin J M.
Afiliación
  • Zhao C; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and rjf1000@cam.ac.uk cz213@cam.ac.uk.
  • Ma D; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Zawadzka M; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Fancy SP; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Elis-Williams L; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Bouvier G; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Stockley JH; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • de Castro GM; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Wang B; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Jacobs S; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and.
  • Casaccia P; Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, New York 10029-6574.
  • Franklin RJ; Wellcome Trust-Medical Research Council Stem Cell Institute and Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0AH, United Kingdom, and rjf1000@cam.ac.uk cz213@cam.ac.uk.
J Neurosci ; 35(33): 11482-99, 2015 Aug 19.
Article en En | MEDLINE | ID: mdl-26290228
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre / Oligodendroglía / Enfermedades Desmielinizantes / Factores de Transcripción SOXB1 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neurosci Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Madre / Oligodendroglía / Enfermedades Desmielinizantes / Factores de Transcripción SOXB1 Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neurosci Año: 2015 Tipo del documento: Article